Fresh bovine bone collagen peptide for supplementing joint nutrition and increasing bone mineral density and preparation method thereof

Through gentle extraction methods and composite enzymatic lysis technology, the problems of purity, molecular weight distribution and biological activity retention during the extraction of fresh bovine collagen peptides were solved, and efficient health effects were obtained, especially in terms of bone density and joint nutritional supplementation. Outstanding performance.

CN118909095AActive Publication Date: 2024-11-08SHANXI NATIVE PEPTIDE TECH CO LTD

Patent Information

Application Number
CN202411107834.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-08
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

The existing extraction technology of fresh bovine collagen peptides has problems with purity, molecular weight distribution and biological activity retention. The use of high temperature and acid-base treatment in the preparation of traditional gelatin leads to unclear degradation of collagen peptides, which affects its health effects.

Method used

Using gentle extraction methods, including bovine bone cleaning, cooking, lipolysis, enzymatic decomposition, filtration, concentration and spray-drying steps, enzymatic lysis using complex protease, control enzymatic conditions and filtration process to obtain high-purity, low molecular weight collagen Protein peptides to avoid high temperature and strong acid and base treatment.

Benefits of technology

It improves the biological activity and absorption efficiency of collagen peptides, enhances its health benefits in the human body, and especially shows significant effects in supplementing joint nutrition and increasing bone density.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004991326120000081
    Figure BDA0004991326120000081
  • Figure BDA0004991326120000091
    Figure BDA0004991326120000091
  • Figure BDA0004991326120000092
    Figure BDA0004991326120000092
Patent Text Reader

Abstract

The invention belongs to the technical field of bioactive peptide processing, and particularly relates to a fresh bovine bone collagen peptide for supplementing joint nutrition and increasing bone mineral density and a preparation method of the fresh bovine bone collagen peptide. The preparation method comprises the following steps: performing enzymolysis, wherein compound protease carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin are used in the enzymolysis; the mass ratio of carboxypeptidase to aminopeptidase to neutral protease to phytase to trypsin is (0.5-1): (0.5-1): (2-4): (1-3): (1-3). The molecular weight of the prepared collagen peptide is less than 5000 Daltons, and the collagen peptide can effectively improve bone mineral density, bone mineral content, bone biomechanical characteristics and bone metabolism indexes, and has good health care and treatment effects on old osteoporosis fracture patients.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioactive peptide processing, and specifically relates to fresh bovine collagen peptides for supplementing joint nutrition and increasing bone density and a preparation method thereof. Background Art

[0002] Fresh bovine bone collagen peptide is a small molecule peptide obtained by processing collagen extracted from bovine bones. It is easily absorbed by the human body and has many health benefits, including beauty and skin care, calcium supplementation and bone health, and improving immunity.

[0003] The extraction method of fresh bovine bone collagen peptides has a significant impact on their final efficacy. Different extraction methods not only affect the purity, molecular weight distribution and biological activity of collagen peptides, but also further affect their absorption and utilization efficiency in the human body, thereby affecting their final health effects. The extraction of fresh bovine bone collagen peptides usually involves multiple steps such as raw material pretreatment, steaming, enzymatic hydrolysis, filtration, purification, concentration and drying. Each of these steps may have an impact on the quality and efficacy of the final product. Specifically, it is reflected in (1) purity and molecular weight distribution: during the extraction process, impurities can be removed and the purity of collagen peptides can be improved through fine filtration and purification steps. High-purity collagen peptides are easier to be absorbed by the human body, thereby more effectively exerting their health effects. Molecular weight distribution is also an important factor affecting efficacy. Smaller molecular weights mean higher biological activity because they are more likely to pass through the cell membrane and enter the cell to exert their effects. Therefore, by controlling the enzymatic hydrolysis conditions, collagen peptides with a specific molecular weight distribution can be obtained to optimize their efficacy. (2) Retention of biological activity: During the extraction process, high temperature, strong acid, strong alkali and other conditions should be avoided as much as possible to avoid destroying the biological activity of collagen peptides. Mild extraction conditions can maximize the retention of the original biological activity of collagen peptides, thereby ensuring the health benefits of collagen peptides. (3) Absorption and utilization: The extraction method will also affect the absorption and utilization efficiency of collagen peptides in the human body. For example, collagen peptide powder obtained by spray drying and other methods has better solubility and dispersibility, making it easier to be absorbed and utilized by the human body. (4) Selection of raw materials: In the preparation of ordinary collagen peptides, gelatin is often used as a raw material. At present, the best edible gelatin is made from the skin and bones of livestock such as cattle, sheep, and pigs. The source of raw materials is unstable and the safety is not guaranteed. In addition, there is a problem of blending edible gelatin with industrial gelatin (using the scraps cut from leather after tanning in leather factories as raw materials), which poses a great safety hazard in the field of food processing. In addition, gelatin is currently widely produced by the alkaline method at home and abroad. The specific alkaline process is: raw material sorting (sorting and sorting different types of raw materials), lime water pre-soaking (immersing the raw materials in a certain concentration of lime water for 7-15 days), washing and neutralization (after washing, neutralize the remaining lime with acid, which generally takes 3-5 days to complete), gelatin boiling and concentration (heating the raw materials after acid and alkali treatment in the extraction tank to boil gelatin), gel drying (the concentrated gelatin liquid is dried and crushed to obtain the finished product). The process of preparing gelatin from animal skins or bones involves high-temperature cooking or acid and alkali treatment. The degradation law of collagen in this process is not very clear at present, but it can be determined that the polypeptide sequence in gelatin caused by thermal degradation or acid and alkali treatment is not completely consistent; in addition, the gelatin preparation process also affects the amino acid composition of collagen. For example, thermal degradation or acid treatment causes deamidation of glutamine or asparagine, which affects the amino acid composition of gelatin and the sequence of polypeptides therein.Finally, the collagen peptide processed with gelatin loses the smell of the substance itself, the nutritional value is greatly reduced, and the product efficacy is also greatly reduced.

[0004] Fresh bovine bone collagen peptide powder is made from fresh bovine bones. It is made through a variety of processes such as water extraction and enzymatic hydrolysis after the bones are cleaned and crushed. No chemical reagents are added during the production process. It is green and healthy, ensuring that the original nutrition of the material is not destroyed.

[0005] In summary, the extraction method of fresh bovine bone collagen peptides has an important influence on its final efficacy. At present, the extraction technology of collagen peptides is still developing, but there is still a problem of insufficient technological innovation. How to develop high-quality and highly active collagen peptide products to better exert their health effects is one of the problems that need to be solved urgently. Summary of the invention

[0006] In order to solve the above problems, the present invention provides a method for extracting fresh bovine collagen peptides, and the obtained bovine collagen peptides have better health care effects.

[0007] In one aspect, the present invention provides a method for preparing bovine collagen peptide, comprising the following steps:

[0008] S1. Pretreatment: washing and crushing the cattle bones to obtain bone blocks;

[0009] S2, steaming: steaming the bone blocks in step S1 to obtain bone broth;

[0010] S3, fat removal: The bone broth of step S2 is subjected to three-phase separation into bone oil, liquid and bone residue to obtain a crude collagen solution after degreasing.

[0011] S4, adding a composite protease to the crude collagen solution obtained in step S3 for enzymatic hydrolysis to obtain a collagen peptide solution;

[0012] S5, filtration: filtering the collagen peptide solution of step S4 to obtain a purified collagen peptide solution;

[0013] S6, concentration: concentrating the purified collagen peptide solution in step S5 under reduced pressure to obtain a concentrated solution;

[0014] 98 S7, drying: spray drying the concentrated solution of step S6 to obtain bovine collagen peptide powder; 99 the composite protease is carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin. 100 Specifically, the bovine bone can be selected from fresh, safe and pollution-free bovine shank bone.

[0015] 101 Specifically, the cooking conditions in step S2 may be: 100-120°C, 1.5-2.0 kPa.

[0016] 102 Preferably, the cooking conditions in step S2 may be: 100-110° C., 1.8-2.0 kPa.

[0017] 103 Further preferably, the cooking conditions in step S2 may be: 110° C., 2.0 kPa.

[0018] 104 Specifically, the amount of the composite protease added in step S4 can be 2‰105-5‰ of the crude collagen content, such as 2‰, 3‰, 4‰, 5‰ and any point within the range.

[0019] 106 Preferably, in some embodiments, the amount of the compound protease added in step S4 may be 2‰ of the weight of the crude collagen 107 solution;

[0020] 108 In some other embodiments, the added amount of the composite protease in step S4 can be 5‰ of the weight of the crude collagen solution.

[0021] 110 Specifically, the enzymatic hydrolysis conditions in step S4 can be 40-50°C for 2-4h.

[0022] 111 Preferably, the enzymatic hydrolysis conditions in step S4 can be 40-45°C for 2-3h.

[0023] 112 Further preferably, the enzymatic hydrolysis conditions in step S5 may be 45°C for 3h.

[0024] 113 Specifically, the mass ratio of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin can be 114 0.5-1:0.5-1:2-4:1-3:1-3.

[0025] 115 Further specifically, in some embodiments, the mass ratio of the carboxypeptidase, aminopeptidase, neutral protease, phytase 116 and trypsin can be 0.5:0.5:4:1:1;

[0026] 117 In some other embodiments, the 118 mass ratio of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin can be 1:1:2:3:3.

[0027] 119 Specifically, the enzyme activities of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin are 120 10,000-50,000 U / g, 10,000-100,000 U / g, 100,000-300,000 U / g, 50,000-150,000 U / g and 2000-6000 U / g, respectively. 121 Further specifically, the enzyme 122 activities of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin are 122 10,000-30,000 U / g, 100,000-60,000 U / g, 200,000-300,000 U / g, 100,000-150,000 U / g and 123 2000-5000 U / g, respectively.

[0028] 124 Preferably, the enzymatic activities of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin are 125 respectively: 30,000 U / g, 60,000 U / g, 200,000 U / g, 100,000 U / g and 4000 U / g.

[0029] 126 Specifically, the filtration in step S5 is ceramic membrane, nanofiltration and ultrafiltration in sequence; the molecular weight of the collagen peptide in the collagen peptide pure 127 solution is less than 8000 Daltons.

[0030] 128 More specifically, the ultrafiltration can be a three-step ultrafiltration method.

[0031] 129 Preferably, the first step is ultrafiltration through an ultrafiltration membrane of 20000-30000 Daltons; the second step is ultrafiltration through an ultrafiltration membrane of 13012000-18000 Daltons; the third step is ultrafiltration through an ultrafiltration membrane of 5000-8000 Daltons. 131 Further preferably, the first step is ultrafiltration through an ultrafiltration membrane of 20000 Daltons; the second step is ultrafiltration through an ultrafiltration membrane of 15000132 Daltons; the third step is ultrafiltration through an ultrafiltration membrane of 5000 Daltons.

[0032] 133 More specifically, the molecular weight of the collagen peptide is less than 5000 Daltons.

[0033] 134 Specifically, the reduced pressure concentration condition in step S6 may be: 0.1-0.3 MPa.

[0034] 135 More specifically, the reduced pressure concentration condition in step S6 may be: 0.1-0.2 MPa.

[0035] 136 Preferably, the condition of reduced pressure concentration in step S6 may be: 0.1 MPa.

[0036] 137 Specifically, the spray drying conditions in step S7 can be: the air inlet temperature can be 138180-200°C, the air outlet temperature can be 85-100°C, and the high-pressure homogenizing pump pressure can be 60-80kg.

[0037] 139 More specifically, the spray drying conditions in step S7 may be: the air inlet temperature may be 140 190-200°C, the air outlet temperature may be 95-100°C, and the high-pressure homogenizing pump pressure may be 70-80kg.

[0038] 141 Preferably, the spray drying conditions in step S7 may be: the air inlet temperature may be 190° C., the air outlet temperature 142 may be 95° C., and the high-pressure homogenizing pump pressure may be 70 kg.

[0039] 143 In another aspect, the present invention provides bovine collagen peptide obtained by the aforementioned preparation method.

[0040] 144 In another aspect, the present invention provides the use of the aforementioned bovine collagen peptide in the preparation of a medicine for supplementing joint nutrition and increasing 145 bone density.

[0041] 146 On the other hand, the present invention provides the use of the aforementioned bovine collagen peptide in the preparation of food for supplementing joint nutrition and increasing 147 bone density.

[0042] 148 On the other hand, the present invention provides the use of the aforementioned bovine collagen peptide in the preparation of health products for supplementing joint nutrition and increasing 149 bone density.

[0043] 150 Technical effects achieved by the present invention: 151 (1) The fresh bovine collagen peptide provided by the present invention can effectively increase the bone density and bone mineral content of castrated mice.

[0044] 153(2) The fresh bovine collagen peptide provided by the present invention can effectively improve the bone biomechanical 154 properties of castrated mice.

[0045] (3) The fresh bovine collagen peptide provided by the present invention can effectively improve the bone metabolism indicators of elderly patients with osteoporosis fractures.

[0046] (4) The fresh bovine collagen peptide provided by the present invention can effectively improve the bone density of elderly patients with osteoporosis fractures. DETAILED DESCRIPTION

[0047] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.

[0048] The purchase source of the enzyme of the present invention is:

[0049] Carboxypeptidase, Nanning Dongheng Huadao Biotechnology Co., Ltd., 30,000 U / g;

[0050] Aminopeptidase, Shandong Longkote Enzyme Preparation Co., Ltd., 60,000 U / g;

[0051] Neutral protease, Nanning Dongheng Huadao Biotechnology Co., Ltd., 200,000 U / g;

[0052] Phytase, Cangzhou Xiasheng Enzyme Biotechnology Co., Ltd., 100,000 U / g;

[0053] Trypsin, Nanning Dongheng Huadao Biotechnology Co., Ltd., 4000U / g.

[0054] Example 1

[0055] A method for preparing fresh bovine collagen peptide comprises the following steps:

[0056] S1. Raw material selection: Choose fresh, safe and pollution-free beef shank bones as raw materials.

[0057] S2. Pretreatment: The selected cattle bones are cleaned to remove impurities and blood stains on the surface. Then, the cattle bones are crushed into 2 cm bone blocks by a bone crusher.

[0058] S3. Steaming: Put the processed beef bones into a steaming tank for steaming. The steaming temperature is 110°C and the pressure is 2.0 kPa.

[0059] S4. Use a three-phase horizontal screw centrifuge to separate the three phases of bone oil, liquid and bone residue to ensure the purity of the separated liquid. Then filter the liquid to remove the fat in the bone soup and obtain a crude collagen solution.

[0060] S5. Enzymatic hydrolysis: add 2‰ w / w of composite protease (carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin in a mass ratio of 0.5:0.5:4:1:1) to the crude collagen solution, and perform enzymatic hydrolysis at 45°C for 3h. After the enzymatic hydrolysis is completed, inactivate the enzyme at high temperature, centrifuge and take the supernatant to obtain the collagen peptide solution.

[0061] 183S6. Filtration: The collagen peptide solution is filtered through a ceramic membrane and the filtrate is collected; the clarified filtrate after 184 filtration is then subjected to nanofiltration and the retentate is collected; the collected retentate is treated by a three-step ultrafiltration 185 method: first, ultrafiltration is performed through an ultrafiltration membrane with a pore size of 20,000 Daltons and the filtrate is collected; then the filtrate is ultrafiltered through an ultrafiltration membrane with a pore size of 15,000 Daltons and the filtrate is collected; then the filtrate is passed through a membrane with a pore size of 5000 Daltons to separate protein peptides with a molecular weight less than 5000 Daltons to obtain a purified collagen peptide solution.

[0062] 189S7. Concentration: The purified collagen peptide solution is concentrated under reduced pressure to obtain a concentrated solution. During the reduced pressure concentration, the pressure is controlled to be 0.1 MPa.

[0063] 191S8, drying: the concentrated solution obtained in step S8 is spray dried by atomizing granulation equipment to obtain bovine collagen peptide powder. The conditions for spray drying by atomizing granulation equipment are: inlet air temperature is 190°C, outlet air temperature is 95°C, and high pressure homogenizing pump pressure is 70kg.

[0064] The enzymatic activity of the carboxypeptidase described in 194 is 10,000-50,000 U / g, the enzymatic activity of the aminopeptidase is 10,000-100,000 U / g, the enzymatic activity of the neutral protease described in 195 is 100,000-300,000 U / g, the enzymatic activity of the phytase is 50,000-150,000 U / g, and the enzymatic activity of the trypsin described in 196 is 2000-6000 U / g.

[0065] The enzyme activities of this embodiment are as follows: the enzymatic activity of the carboxypeptidase is 30,000 U / g, the enzymatic activity of the aminopeptidase is 19.86 million U / g, the enzymatic activity of the neutral protease is 200,000 U / g, the enzymatic activity of the phytase is 100,000 U / g, and the enzymatic activity of the trypsin is 4000 U / g.

[0066] 200 Example 2

[0067] 201 A method for preparing fresh bovine bone collagen peptide, which differs from Example 1 in step S5: 202 S5, enzymatic hydrolysis: adding 5‰ w / w of a composite protein 203 enzyme (carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin in a mass ratio of 1:1:2:3:3) based on the crude collagen content to a crude collagen solution, 204 performing enzymatic hydrolysis at 45°C for 3h, inactivating the enzyme at high temperature after the enzymatic hydrolysis is completed, and centrifuging to obtain the supernatant to obtain a collagen 205 peptide solution.

[0068] 206 Comparative Example 1

[0069] 207 A method for preparing fresh bovine bone collagen peptide, which differs from Example 1 in that 208 phytase in step S5 is replaced by trypsin, i.e., a composite protease (carboxypeptidase, aminopeptidase, neutral protease and trypsin in a mass ratio of 0.5:0.5:4:2) of 2‰ w / w 209 of the crude collagen content is added to the crude collagen solution.

[0070] 210 Comparative Example 2

[0071] A method for preparing fresh bovine bone collagen peptides, which differs from Example 1 in that the trypsin in step S5 is replaced by phytase, that is, a composite protease (carboxypeptidase, aminopeptidase, neutral protease and phytase in a mass ratio of 0.5:0.5:4:2) of 2‰ w / w of the crude collagen content is added to the crude collagen solution.

[0072] Comparative Example 3

[0073] A method for preparing fresh bovine bone collagen peptides, which differs from Example 1 in that trypsin and phytase are not added in step S5, that is, a composite protease (carboxypeptidase, aminopeptidase and neutral protease in a mass ratio of 0.5:0.5:4) of 2‰ w / w of the crude collagen content is added to the crude collagen solution.

[0074] Experimental Example 1 Effect of Fresh Bovine Collagen Peptide on Osteoporosis

[0075] 1.1 Animal modeling

[0076] SPF Balb / c mice, healthy, 12-week-old female non-pregnant.

[0077] Modeling method:

[0078] (1) Mice were anesthetized intraperitoneally with 3% sodium pentobarbital (40 mg / kg) and placed in a supine position, and the abdominal hair was removed.

[0079] (2) Under sterile conditions, cut the skin and muscle layer along the midline of the abdomen at the level of the groin to expose the abdominal cavity.

[0080] (3) The uterus was separated and the ovaries were removed. After cleaning the wound, the skin and the base layer were sutured in two layers. After the mice woke up, they were placed back into a clean cage and then returned to the breeding room for feeding. The condition and mortality of the mice were regularly observed and recorded.

[0081] (4) Three days after surgery, each mouse was injected with 40,000 units of penicillin per day to prevent infection.

[0082] (5) In the control group, only about 1g of fat around the ovaries was removed, while the ovaries were retained. Other treatments were the same.

[0083] Successful modeling criteria: The weight of the rats in the castration group increased rapidly, their activity decreased, and their fur was dull and slightly gray, while the weight of the mice in the control group increased slowly, their fur was shiny, and their activity was normal. The estradiol level and femoral BMD in the castration group decreased significantly.

[0084] 1.2 Animal grouping and drug administration

[0085] The castrated mice were divided into a model group, a positive drug group, an example 1 group, an example 2 group, a comparative example 1 group, a comparative example 2 group, a comparative example 3 group, each group of 15 mice, and the above-mentioned control group of 15 mice was taken as a control group. The control group and the model group were given an equal amount of saline, and the positive drug group was given 12 μg / kg by gavage. Group 1, Example 2 group, Comparative Example 1 group, Comparative Example 2 group, and Comparative Example 3 group were given 20 mg / kg of the corresponding bovine collagen peptide powder of the examples and comparative examples by gavage. All animals were given once a day for 10 weeks.

[0086] 1.3 Detection indicators

[0087] 1.3.1 Bone mineral density (BMD) testing

[0088] 2 hours after the last administration of bone density drug, the anesthetized rats were placed supine on the test table of the bone densitometer, the femurs of the rats were stretched to the maximum extent to fully expose the femurs to X-rays, and the bone densitometer was turned on to scan the bilateral femurs and measure the bone density values.

[0089] 1.3.2 Determination of bone mineral content (BMC)

[0090] After testing BMD, the femurs of the rats were removed, the surrounding muscle tissues were cleaned, and the bones were dried in a drying oven (temperature 90°C) for 1 hour, and weighed on a balance (accuracy: 0.1 mg). After carbonization in an electric furnace, the bones were placed in a muffle furnace (800°C) for 2 hours. After the ashes were cooled, they were weighed on an electronic balance. 10L of 3% nitric acid solution was added with 0.05g and 0.1g of ash, respectively, and transferred to a 25L colorimetric tube. The solution was colorless and transparent and was placed at room temperature for 48 hours to test the bone mineral content.

[0091] 1.3.3 Bone biomechanics measurement

[0092] The experiment used a CTM2050S universal tensile testing machine. The full length of the right femur was taken and immersed in physiological saline at room temperature for 3 hours. The femur was taken out and restored to room temperature. The two ends were cast with glue and placed on a three-point compression test bench with a spacing of 22mm. The direction of the short axis of the specimen cross section was consistent with the direction of acceleration. The maximum loading speed was 2mm / min. The pressure frame switch was started. After the femur was broken, the computer obtained the data of maximum load, bone stress, elastic modulus, energy absorption and structural strength.

[0093] The experimental results were expressed as mean ± standard deviation and analyzed using SPSS 20.0 software. One-way analysis of variance was used for comparison among multiple groups, and t-test was used for equality of variance, while non-parametric test was used for inequality of variance.

[0094] 1.4 Results and Analysis

[0095] 14.1 Bone density test results

[0096] The results are shown in Table 1:

[0097] Table 1 Bone density test data

[0098]

[0099]

[0100] Note: Compared with the control group, #P<0.05, ##P<0.01; compared with the model group, *P<0.05, **P<0.01.

[0101] The above results show that compared with the model group, both the positive drug and Example 1-2 can effectively improve the bone density of mice, and the effect of Example 1-2 is worse than that of the positive drug. Comparative Example 1-2 also has a certain effect on improving bone density, but the effect is not as significant as that of Example 1-2.

[0102] 14.2 Bone Mineral Content Test Results

[0103] The results are shown in Table 2:

[0104] Table 2 Bone mineral content test data

[0105] Group Bone mineral content / g Control group 0.40±0.02** Model Group 0.36±0.01## Positive drug group 0.41±0.03** Example 1 Group 0.41±0.02** Example 2 Group 0.40±0.02** Comparative Example 1 0.39±0.02** Comparative Example 2 <![CDATA[0.38±0.01* # ]]> Comparative Example 3 0.37±0.01##

[0106] Note: Compared with the control group, #P<0.05, ##P<0.01; compared with the model group, *P<0.05, **P<0.01.

[0107] The above results show that compared with the model group, the positive drug, Examples 1-2 and Comparative Example 1 can effectively increase the bone mineral content of mice, and there is no significant difference with the control group. Comparative Example 2 is less effective than Examples 1-2 and Comparative Example 1, and Comparative Example 3 has no effect on increasing the bone mineral content of mice.

[0108] 1.3.3 Bone biomechanical test results

[0109] The results are shown in Table 3:

[0110] Table 3 Bone biomechanical test data

[0111]

[0112]

[0113] Note: Compared with the control group, #P<0.05, ##P<0.01; compared with the model group, *P<0.05, **P<0.01.

[0114] The above results indicate that there are no significant differences in the data of maximum load, energy absorption, and structural strength in bone biomechanical tests among the groups, and there is no statistical significance. In terms of bone stress, compared with the model group, both the positive drug and Examples 1-2 can significantly increase the bone stress of mice, and the effect is comparable to that of the control group; the effects of Comparative Examples 1-3 are significantly inferior to those of Examples 1-2. In terms of elastic modulus, compared with the model group, the positive drug, Examples 1-2, and Comparative Examples 1-3 all have an increasing effect. Among them, Examples 1-2 are comparable to the positive drug, and the effect is significantly better than that of Comparative Examples 1-3.

[0115] Experimental Example 2 Effect of Fresh Bovine Bone Collagen Peptide on Fractures in Senile Osteoporosis

[0116] 2.1 Population Screening Criteria

[0117] Inclusion criteria: aged 60-80 years old; meeting the diagnosis of fractures in senile osteoporosis according to the diagnostic criteria; having no other serious infectious diseases, tumors, etc.; the patients voluntarily participating and signing the informed consent form.

[0118] The diagnostic criteria for fractures in senile osteoporosis refer to the "Diagnosis and Treatment Guidelines for Primary Osteoporosis". The diagnostic criteria for osteoporosis are: hip or vertebral fragility fractures; the T value of axial bone mineral density or distal 1 / 3 radius bone mineral density measured by dual-energy X-ray absorptiometry ≤ -2.5; bone mineral density measurement meeting low bone mass (-2.5 < T value < -1.0) + fragility fractures of the proximal humerus, pelvis, or distal forearm; meeting one of the three criteria.

[0119] Exclusion criteria: aged < 60 years old or > 80 years old; patients with fractures caused by other reasons; patients with allergic constitution or allergic to the drugs related to this study; patients with combined tumors, severe hepatic and renal insufficiency; patients who are not voluntary or have not signed the informed consent form.

[0120] 2.2 Grouping and Drug Administration

[0121] 120 eligible patients with fractures in senile osteoporosis were randomly divided into 6 groups. The positive drug group was given calcitriol soft capsules at a dose of 0.25 μg / time, 3 times a day. The first group of Examples, the second group of Examples, the first group of Comparative Examples, the second group of Comparative Examples, and the third group of Comparative Examples were given at a dose of 150 mg / time, 2 times a day. The curative effects were observed after 6 groups were treated for 7 weeks.

[0122] 2.3 Detection Indexes

[0123] 2.3.1 Detection of Bone Metabolism Indexes

[0124] 5 mL of venous blood was drawn from the patients before and after treatment, centrifuged

[0125] and the supernatant was taken and stored at low temperature. The PINP, β-CTX, and OC in the serum of the patients were measured using an elisa kit.

[0126] 2.3.2 Bone density test

[0127] The changes of bone density in the two groups of patients before and after treatment were detected using American Prodigy dual-energy X-ray absorptiometry.

[0128] 2.4 Test results

[0129] 2.4.1 Results of bone metabolism indexes in patients before and after treatment

[0130] The test results are shown in Table 4:

[0131] Table 4 Bone metabolism index test data of patients before and after treatment

[0132]

[0133] Note: Compared with the positive drug group, #P<0.05, ##P<0.01; compared with before treatment, *P<0.05, **P<0.01.

[0134] The above results show that the positive drug and Example 1-2 can significantly reduce PINP and significantly increase OC compared with before treatment, and Examples 1-2 are superior to the positive drug in terms of effect. There is no significant difference in reducing β-CTX in the positive drug group compared with before treatment, and Examples 1-2 have significant differences compared with before treatment and the positive drug.

[0135] 2.4.1 Results of bone density tests of patients before and after treatment

[0136] The test results are shown in Table 5:

[0137] Table 5 Bone density test data of patients before and after treatment

[0138]

[0139] Note: Compared with the positive drug group, # P<0.05, ## P<0.01; compared with before treatment, *P<0.05, **P<0.01.

[0140] The above results show that the positive drug, Examples 1-2 and Comparative Example 1 all have the effect of enhancing bone density compared to before treatment, among which the effect of Examples 1-2 is significantly better than that of the positive drug and Comparative Example 1.

Claims

1. A method for preparing bovine collagen peptide, It is characterized in that The following steps are involved: S1. Pretreatment: washing and crushing the cattle bones to obtain bone blocks; S2, steaming: steaming the bone blocks in step S1 to obtain bone broth; S3, fat removal: the bone broth of step S2 is subjected to three-phase separation of bone oil, liquid and bone residue to obtain a crude collagen solution after degreasing; S4, adding a composite protease to the crude collagen solution obtained in step S3 for enzymatic hydrolysis to obtain a collagen peptide solution; S5, filtration: filtering the collagen peptide solution of step S4 to obtain a purified collagen peptide solution; S6, concentration: concentrating the purified collagen peptide solution in step S5 under reduced pressure to obtain a concentrated solution; S7, drying: spray drying the concentrated solution of step S6 to obtain bovine collagen peptide powder; The composite protease is carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin.

2. The preparation method according to claim 1, It is characterized in that The cooking conditions in step S2 are: 100-120° C., 1.5-2.0 kPa.

3. The preparation method according to claim 1, It is characterized in that The added amount of the composite protease in step S4 is 2‰-5‰ w / w of the crude collagen content.

4. The preparation method according to claim 1, It is characterized in that The enzymatic hydrolysis conditions in step S4 are 40-50° C. for 2-4 h.

5. The preparation method according to claim 1, It is characterized in that The mass ratio of the carboxypeptidase, the aminopeptidase, the neutral protease, the phytase and the trypsin is 0.5-1:0.5-1:2-4:1-3:1-3.

6. The preparation method according to claim 5, It is characterized in that The enzyme activities of the carboxypeptidase, aminopeptidase, neutral protease, phytase and trypsin are respectively 10,000-50,000 U / g, 10,000-100,000 U / g, 100,000-300,000 U / g, 50,000-150,000 U / g and 2,000-6,000 U / g.

7. The preparation method according to claim 1, It is characterized in that The filtration in step S5 is ceramic membrane, nanofiltration and ultrafiltration in sequence; the molecular weight of the collagen peptide in the collagen peptide purification solution is less than 8000 Daltons.

8. The preparation method according to claim 7, It is characterized in that The molecular weight of collagen peptides is less than 5000 Daltons.

9. Bovine collagen peptide obtained by the preparation method according to any one of claims 1 to 7.

10. Use of the bovine collagen peptide according to claim 9 in the preparation of medicines, foods or health products for supplementing joint nutrition and increasing bone density.

Citation Information

Patent Citations

  • Yak bone collagen peptide capable of improving abundance function of intestinal microorganisms and preparation method of yak bone collagen peptide

    CN113151391A

  • Bovine bone collagen peptide with functions of relieving fatigue and improving bone mineral density and preparation method of bovine bone collagen peptide

    CN113201065A

  • Bovine bone oligomerization collagen high-calcium peptide powder as well as preparation method and application thereof

    CN116497078A

  • Hydrolyzed collagen for use in reducing blood glucose

    WO2023233008A1

Cited By

  • Preparation method of collagen peptide, nutrition powder composition for promoting wound healing and preparation method, product and application of nutrition powder composition

    CN121574233A

  • Preparation method of fresh bovine bone oligopeptide with functions of protecting cartilage and promoting bone growth as well as product and application of fresh bovine bone oligopeptide

    CN122214452A